These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 735855)

  • 1. Relation between severity of thyrotoxicosis and response to 131I therapy.
    Olsen KJ; Nielsen HE; Hansen HH
    Acta Radiol Oncol Radiat Phys Biol; 1978; 17(6):517-23. PubMed ID: 735855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
    Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
    J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radioiodine therapy of funcitonal autonomy using the functional autonomous volume].
    Seeger T; Emrich D; Sandrock D
    Nuklearmedizin; 1995 Aug; 34(4):135-40. PubMed ID: 7675642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
    Jarløv AE; Hegedüs L; Kristensen LO; Nygaard B; Hansen JM
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):325-9. PubMed ID: 7586602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [TRH and T3 suppression tests after 131I therapy of thyrotoxicosis (author's transl)].
    Tamai H; Tsushimi T; Shizume K; Kuma K; Suematsu H
    Nihon Naibunpi Gakkai Zasshi; 1976 Mar; 52(3):232-42. PubMed ID: 823056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of 125I treatment of thyrotoxicosis.
    Bremner WF; Spencer CA; Ratcliffe WA; Greig WR; Ratcliffe JG
    Clin Endocrinol (Oxf); 1976 May; 5(3):225-34. PubMed ID: 954217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)].
    Glanzmann Ch; Horst W
    Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduced radiation sensitivity of hyperthyroid goiter with endocrine ophthalmopathy (author's transl)].
    Mertz DP; Koch B
    MMW Munch Med Wochenschr; 1977 Jul; 119(28):945-8. PubMed ID: 408626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine turnover studies as a means to predict stable intrathyroidal iodine stores and comments upon its use in the diagnosis and treatment of hyperthyroidism.
    Jonckheer MH; Flamen P; Velkeniers B; Vanhaelst L; Kaufman L
    Thyroid; 1993; 3(1):11-6. PubMed ID: 8499759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of radioactive iodine uptake after treatment of hyperthyroidism with iodine 131.
    Heath RC; Gossain VV; Rovner DR
    South Med J; 1988 May; 81(5):601-5. PubMed ID: 3368812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute changes in thyroid function in patients treated with radioactive iodine.
    Shafer RB; Nuttall FQ
    Lancet; 1975 Oct; 2(7936):635-7. PubMed ID: 52005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Function of the thyroid gland following radio-iodine therapy in hyperthyroidism: thyroxine, triiodothyronine and TSH reaction after TRH stimulation].
    Pickardt CR; Einhäuser G; Erhardt F; Heinze HG; Horn K; Scriba PC
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1874-7. PubMed ID: 829464
    [No Abstract]   [Full Text] [Related]  

  • 14. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis.
    Toft AD; Irvine WJ; Hunter WM; Ratcliffe JG; Seth J
    J Clin Endocrinol Metab; 1974 Sep; 39(3):607-9. PubMed ID: 4412033
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
    Ross DS; Daniels GH; De Stefano P; Maloof F; Ridgway EC
    J Clin Endocrinol Metab; 1983 Aug; 57(2):250-3. PubMed ID: 6688081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis.
    Goolden AW; Stewart JS
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):217-22. PubMed ID: 3708873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of inorganic iodide after 131I therapy for hyperthyroidism.
    Schimmel M; Utiger RD
    Clin Endocrinol (Oxf); 1977 Apr; 6(4):329-32. PubMed ID: 862209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function in patients treated with radioactive iodine for thyrotoxicosis.
    Tunbridge WM; Harsoulis P; Goolden AW
    Br Med J; 1974 Jul; 3(5923):89-92. PubMed ID: 4855207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of two different dosage calculation protocols of iodine-131 in the treatment of hyperthyroidism.
    Thientunyakit T; Thongmak S; Premprapha T
    J Med Assoc Thai; 2010 Aug; 93(8):969-77. PubMed ID: 20718174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.